Media coverage
1
Media coverage
Title Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients; X-MEN Media name/outlet Clinical Trials.gov Country/Territory United States Date 18/10/2 Persons Seung Hyun Kim, Heejin Kim